Results 101 to 110 of about 37,390 (254)

Peripheral regulatory cells immunophenotyping in Primary Sjögren's Syndrome: a cross-sectional study [PDF]

open access: yes, 2013
INTRODUCTION: IL-10--producing B cells, Foxp3-expressing T cells (Tregs) and the IDO-expressing dendritic cells (pDC) are able to modulate inflammatory processes, to induce immunological tolerance and, in turn, to inhibit the pathogenesis of autoimmune ...
Gabriela Hernández-Molina   +5 more
core   +1 more source

TAM pathway proteins as novel salivary biomarkers for periodontitis

open access: yesJournal of Periodontology, EarlyView.
Abstract Background The identification of molecular biomarkers that help clinicians in early diagnosis is a key focus of periodontal research. The major aim of this cross‐sectional observational study was to assess whether salivary TAM pathway protein levels have the potential to discriminate between periodontally healthy or gingivitis controls and ...
Karina Mendes   +7 more
wiley   +1 more source

Salivary transforming growth factor alpha in patients with Sjögren's syndrome and reflux laryngitis

open access: yesBrazilian Journal of Otorhinolaryngology, 2014
Introduction: Saliva plays a key role in the homeostasis of the digestive tract, through its inorganic components and its protein growth factors.
Marco Antonio dos Anjos Corvo   +5 more
doaj   +1 more source

Mesenteric Panniculitis in Sjögren’s Syndrome: A New Systemic Manifestation to Consider? [PDF]

open access: yes, 2018
The association between mesenteric panniculitis and Sjögren's syndrome, although rare, is starting to be recognized. Usually, mesenteric panniculitis is symptomatic, presenting with either general or gastrointestinal symptoms.
Carvalho, Armando   +4 more
core   +2 more sources

Ocular facial myositis and sialadenitis presenting with new onset ulcerative colitis

open access: yesJPGN Reports, EarlyView.
Abstract Extra‐intestinal manifestations of inflammatory bowel disease (IBD) can involve most organ systems, although the immunologic underpinnings are not well understood. Most patients who present with an extra‐intestinal manifestation have a single site of extra‐intestinal involvement; however, a small cohort presents with multiple different sites ...
Nicole Du, Nicole Mendez, Anil Darbari
wiley   +1 more source

Labial salivary gland biopsy: a crucial method for confirming seronegative Sjogren’s syndrome—a case report

open access: yesBulletin of the National Research Centre
Background Sjogren’s syndrome is an autoimmune disease that affects exocrine glands like sweat glands, salivary glands, and lacrimal glands. Dentists frequently encounter these patients and have an important role in establishing the diagnosis.
Satyasai S. G. Romala   +8 more
doaj   +1 more source

Long‐Term Dermoscopic Evolution of Reticular Erythematous Mucinosis: Case Report

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Reticular erythematous mucinosis is a rare dermatosis with a challenging diagnosis. To date, its dermoscopic features have not been well characterised in the literature. Only a limited number of case reports have described dermoscopic findings that may be indicative of the disorder, including the presence of dotted and linear vessels, as well ...
Grażyna Kamińska‐Winciorek   +4 more
wiley   +1 more source

Sjögren's syndrome concurrent with protein‐losing gastroenteropathy with secondary systemic capillary leak syndrome : A case report

open access: yesClinical Case Reports, 2018
Key Clinical Message Sjögren's syndrome concurrent with protein‐losing gastroenteropathy can develop into secondary systemic capillary leak syndrome.
Kei Watanabe   +9 more
doaj   +1 more source

Psychiatric disorder as clinical presentation of primary Sjögren's syndrome: two case reports

open access: yesAnnals of General Psychiatry, 2010
Psychiatric disorders in primary Sjögren's syndrome constitute a possible clinical reality that each practitioner must be able to recognise and treat.
Bonacini Federica   +2 more
doaj   +1 more source

MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjögren's syndrome [PDF]

open access: yes, 2013
Objective: To establish an easy and practical assay for identifying systemic interferon (IFN) type I bioactivity in patients with primary Sjögren's syndrome (pSS).
Brkic, Z. (Zana)   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy